ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L02BB03 | G | Bicalutamide - 50mg | 5889 | 222451/08 | BICAMIDE | 50mg | 28 | Tablet, film coated | Oral | Nobel Pharm Plus SARL | Genepharm SARL | Greece | 1,451,753 L.L | 23.08 | B | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L02BB03 | B | Bicalutamide - 50mg | 11511 | 92121/1 | CASODEX | 50mg | 28 | Tablet, film coated | Oral | Omnipharma | Corden Pharma GmbH | Germany | 3,777,541 L.L | 23.08 | B | Laboratoires Juvisé Pharmaceuticals | France | 2/5/2024 | 0 |
L02BB03 | G | Bicalutamide - 50mg | 8881 | 103816/1 | BICALUTAMIDE ACCORD | 50mg | 28 | Tablet, film coated | Oral | Mediterranean Pharmaceutical Company | Accord Healthcare Limited | UK | 1,382,814 L.L | 23.08 | A2 | Accord Healthcare Limited | UK | 2/5/2024 | 0 |
L02BB03 | G | Bicalutamide - 50mg | 11016 | 51722/1 | BICALUTAMIDE BIOGARAN | 50mg | 30 | Tablet, coated | Oral | Commercial and Trading Ressources SAL (CTR) | Synthon Hispania SL | Spain | 4,315,078 L.L | 23.08 | B | Laboratoires Biogaran | France | 2/5/2024 | 0 |
L02BB03 | G | Bicalutamide - 50mg | 11630 | 111122/1 | BICALUTAMIDE GP PHARM | 50mg | 28 | Tablet, film coated | Oral | Mediterranean Pharmaceutical Company | GP-Pharm, SA | Argentine | 1,306,215 L.L | 23.08 | A2 | Pharminicio SL | Spain | 2/5/2024 | 0 |
L02BB03 | G | Bicalutamide - 50mg | 5158 | 24717/07 | PROSMIDE | 50mg | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 3,597,914 L.L | 23.08 | B | 2/5/2024 | 0 |